Apellis Pharmaceuticals, Inc. Annual Operating Margin in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Apellis Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from 2020 to 2023.
  • Apellis Pharmaceuticals, Inc. Operating Margin for the quarter ending June 30, 2024 was -49.8 %, a 85% increase year-over-year.
  • Apellis Pharmaceuticals, Inc. annual Operating Margin for 2023 was -130 %, a 83.5% increase from 2022.
  • Apellis Pharmaceuticals, Inc. annual Operating Margin for 2022 was -788 %, a 2.15% increase from 2021.
  • Apellis Pharmaceuticals, Inc. annual Operating Margin for 2021 was -806 %, a 845% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -130 +658 +83.5% Jan 1, 2023 Dec 31, 2023
2022 -788 +17.3 +2.15% Jan 1, 2022 Dec 31, 2022
2021 -806 -720 -845% Jan 1, 2021 Dec 31, 2021
2020 -85.3 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.